The combination of the two agents reverses almost completely the liver features of NASH, including hepatocytes ballooning, promoted a shift of bile acid pool toward GPBAR1 biased bile acid species and reversed the pro-atherogenic lipid profile that develop feeding a Western diet. The gene discussed is GPBAR1; the disease is metabolic dysfunction-associated steatohepatitis.